Business Context and Reporting Period
This Form 8-K Current Report was filed by Core Scientific, Inc. on July 22, 2024. The filing discloses the execution of a new employment agreement and equity grants for Todd M. DuChene, who serves as Executive Vice President, Chief Legal and Administrative Officer, Chief Compliance Officer, and Secretary.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation arrangements.
- Base Salary: $500,000 annually.
- Annual Incentive Target: 100% of base salary ($500,000) for 2024, with a guaranteed minimum of $500,000 regardless of performance criteria achievement.
- Equity Grants (2024):
- 1,003,633 time-based Restricted Stock Units (RSUs) vesting over four years.
- 250,909 time-based RSUs vesting quarterly through 2026.
- 83,637 performance-based RSUs vesting over 2024-2026 based on performance goals.
Material Changes
The primary material change is the formalization of Mr. DuChene's compensation package effective July 19, 2024. This includes a guaranteed minimum bonus for 2024 and significant new equity awards totaling approximately 1.34 million RSUs (time-based and performance-based combined).
Outlook, Risks, and Contingencies
Severance and Change in Control: The agreement outlines specific severance provisions if Mr. DuChene is terminated without Cause.
- Standard Termination: 12 months of continued base salary, unpaid bonuses, and accelerated vesting of Legacy Awards and 2024 Equity Grants (subject to terms).
- Change in Control Termination: Lump-sum payment equal to annual base salary, unpaid retention/transaction benefits, unpaid bonuses, and accelerated vesting of Legacy Awards and 2024 Equity Grants.
Retirement: Accelerated vesting of Legacy Awards and other equity awards is available upon retirement after the Initial Term, subject to release agreements.
Risks: The filing notes that the summary is subject to the full text of the Employment Agreement and award agreements filed as exhibits. The guaranteed bonus structure represents a fixed cost obligation for the company regardless of 2024 performance outcomes.
Investor Verification Checklist
- Verify the total number of outstanding shares and the potential dilution impact of the 1,338,179 new RSUs granted.
- Review the specific performance criteria attached to the 83,637 performance-based RSUs in Exhibit 10.3.
- Confirm the company's current cash position to assess the ability to fund the guaranteed $500,000 bonus and potential severance obligations.
- Examine the definitions of "Cause" and "Protection Period" in the full Employment Agreement (Exhibit 10.1) to understand the triggers for severance.